Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker PATH
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Brad C Brubaker Officer | PATH UiPath, Inc. | 27,404 | $356.3K | 10b5-1 | Nov 9, 2026 | Form 4 ↗ 1 day later · 27,404 shares | Form 144 ↗ |
| Oct 22, 2026 | Raghavendra Malpani Officer | PATH UiPath, Inc. | 29,565 | $405.3K | 10b5-1 | Oct 22, 2026 | Form 4 ↗ 4 days later · 29,565 shares | Form 144 ↗ |
| Oct 15, 2026 | Icevulcan Investments Limited Director, Officer, 10% Stockholder | PATH UiPath, Inc. | 2.50M | $32.6M | 10b5-1 | Oct 15, 2026 | Form 4 ↗ 4 days later · 2.50M shares | Form 144 ↗ |
| Oct 13, 2026 | Brad C Brubaker Officer | PATH UiPath, Inc. | 27,404 | $369.4K | 10b5-1 | Oct 12, 2026 | Form 4 ↗ 28 days later · 27,404 shares | Form 144 ↗ |
| Oct 9, 2026 | Raghavendra Malpani Officer | PATH UiPath, Inc. | 29,564 | $391.7K | 10b5-1 | Oct 9, 2026 | Form 4 ↗ 17 days later · 29,565 shares | Form 144 ↗ |
| Oct 2, 2026 | Ashim Gupta Officer | PATH UiPath, Inc. | 66,052 | $879.8K | 10b5-1 | Oct 2, 2026 | — | Form 144 ↗ |
| Sep 16, 2026 | Raghavendra Malpani Officer | PATH UiPath, Inc. | 138,893 | $2.0M | 10b5-1 | Sep 16, 2026 | Form 4 ↗ 1 day later · 98,429 shares | Form 144 ↗ |
| Sep 11, 2026 | Ashim Gupta Officer | PATH UiPath, Inc. | 117,339 | $1.6M | 10b5-1 | Sep 11, 2026 | Form 4 ↗ 3 days later · 117,339 shares | Form 144 ↗ |
| Aug 19, 2026 | Icevulcan Investments Limited Director, Officer, 10% Stockholder | PATH UiPath, Inc. | 1.40M | $21.8M | 10b5-1 | Aug 19, 2026 | Form 4 ↗ same day · 1.40M shares | Form 144 ↗ |
| Aug 14, 2026 | Hitesh Ramani Officer | PATH UiPath, Inc. | 50,000 | $834.0K | 10b5-1 | Aug 14, 2026 | Form 4 ↗ same day · 50,000 shares | Form 144 ↗ |
| Aug 13, 2026 | Hitesh Ramani Officer | PATH UiPath, Inc. | 25,000 | $381.5K | 10b5-1 | Aug 13, 2026 | Form 4 ↗ 1 day later · 50,000 shares | Form 144 ↗ |
| Jan 26, 2026 | Icevulcan Investments Limited Director, Officer, 10% Stockholder | PATH UiPath, Inc. | 1.00M | $14.8M | 10b5-1 | Jan 26, 2026 | Form 4 ↗ same day · 90,000 shares | Form 144 ↗ |
| Jan 5, 2026 | Ashim Gupta Officer | PATH UiPath, Inc. | 67,468 | $1.1M | 10b5-1 | Jan 5, 2026 | Form 4 ↗ 1 day later · 67,468 shares | Form 144 ↗ |
| Dec 17, 2025 | Icevulcan Investments Limited Director, Officer, 10% Stockholder | PATH UiPath, Inc. | 1.00M | $16.1M | 10b5-1 | Dec 17, 2025 | Form 4 ↗ same day · 45,000 shares | Form 144 ↗ |
| Dec 5, 2025 | Brad C Brubaker Officer | PATH UiPath, Inc. | 27,580 | $509.7K | 10b5-1 | Dec 5, 2025 | Form 4 ↗ 3 days later · 27,580 shares | Form 144 ↗ |
| Oct 17, 2025 | Hitesh Ramani Officer | PATH UiPath, Inc. | 35,000 | $557.5K | 10b5-1 | Oct 17, 2025 | Form 4 ↗ same day · 10,000 shares | Form 144 ↗ |
| Oct 17, 2025 | Icevulcan Investments Limited Director, Officer, 10% Stockholder | PATH UiPath, Inc. | 1.00M | $15.9M | 10b5-1 | Oct 17, 2025 | Form 4 ↗ same day · 45,000 shares | Form 144 ↗ |
| Oct 16, 2025 | Hitesh Ramani Officer | PATH UiPath, Inc. | 10,000 | $166.9K | 10b5-1 | Oct 16, 2025 | Form 4 ↗ same day · 10,000 shares | Form 144 ↗ |
| Oct 15, 2025 | Hitesh Ramani Officer | PATH UiPath, Inc. | 10,000 | $164.8K | 10b5-1 | Oct 15, 2025 | Form 4 ↗ same day · 20,000 shares | Form 144 ↗ |
| Oct 15, 2025 | Brad C Brubaker Officer | PATH UiPath, Inc. | 27,580 | $454.5K | 10b5-1 | Oct 15, 2025 | Form 4 ↗ same day · 27,580 shares | Form 144 ↗ |
| Oct 14, 2025 | Hitesh Ramani Officer | PATH UiPath, Inc. | 10,000 | $171.4K | 10b5-1 | Oct 14, 2025 | Form 4 ↗ 1 day later · 20,000 shares | Form 144 ↗ |
| Oct 14, 2025 | Hitesh Ramani Officer | PATH UiPath, Inc. | 10,000 | $170.5K | 10b5-1 | Oct 13, 2025 | Form 4 ↗ 1 day later · 20,000 shares | Form 144 ↗ |
| Oct 9, 2025 | Ashim Gupta Officer | PATH UiPath, Inc. | 240,874 | $3.8M | 10b5-1 | Oct 9, 2025 | Form 4 ↗ 5 days later · 240,874 shares | Form 144 ↗ |
| Oct 6, 2025 | Brad C Brubaker Officer | PATH UiPath, Inc. | 66,665 | $860.0K | 10b5-1 | Oct 6, 2025 | Form 4 ↗ same day · 66,665 shares | Form 144 ↗ |
| Oct 6, 2025 | Ice Vulcan Holding Limited Director, Officer, 10% Stockholder | PATH UiPath, Inc. | 1.00M | $12.9M | 10b5-1 | Oct 6, 2025 | Form 4 ↗ same day · 122,733 shares | Form 144 ↗ |
| Sep 30, 2025 | Brad C Brubaker Officer | PATH UiPath, Inc. | 16,083 | $202.0K | 10b5-1 | Sep 30, 2025 | Form 4 ↗ 1 day later · 16,083 shares | Form 144 ↗ |
| Sep 24, 2025 | Ice Vulcan Holding Limited Director, Officer, 10% Stockholder | PATH UiPath, Inc. | 1.00M | $12.5M | 10b5-1 | Sep 24, 2025 | Form 4 ↗ same day · 122,733 shares | Form 144 ↗ |
| Jul 23, 2025 | Ice Vulcan Holding Limited Director, Officer, 10% Stockholder | PATH UiPath, Inc. | 1.00M | $12.6M | 10b5-1 | Jul 23, 2025 | Form 4 ↗ same day · 45,000 shares | Form 144 ↗ |
| Jul 2, 2025 | Ashim A Gupta Officer | PATH UiPath, Inc. | 56,322 | $714.7K | 10b5-1 | Jul 2, 2025 | Form 4 ↗ same day · 56,322 shares | Form 144 ↗ |
| Jun 20, 2025 | Ice Vulcan Holding Limited Director, Officer, 10% Stockholder | PATH UiPath, Inc. | 1.00M | $12.4M | 10b5-1 | Jun 20, 2025 | Form 4 ↗ same day · 45,000 shares | Form 144 ↗ |
| May 1, 2025 | Our Three Babies 2021 Trust Officer | PATH UiPath, Inc. | 505 | $6,030 | 10b5-1 | May 1, 2025 | Form 4 ↗ 1 day later · 99,300 shares | Form 144 ↗ |
| May 1, 2025 | Ashim A Gupta Officer | PATH UiPath, Inc. | 98,795 | $1.2M | 10b5-1 | May 1, 2025 | Form 4 ↗ 1 day later · 99,300 shares | Form 144 ↗ |
| May 1, 2025 | Ice Vulcan Holding Limited Director, Officer, 10% Stockholder | PATH UiPath, Inc. | 1.00M | $11.9M | 10b5-1 | May 1, 2025 | Form 4 ↗ same day · 45,000 shares | Form 144 ↗ |
| Apr 3, 2025 | Hitesh Ramani Officer | PATH UiPath, Inc. | 12,500 | $135.3K | 10b5-1 | Apr 3, 2025 | Form 4 ↗ 4 days later · 12,500 shares | Form 144 ↗ |
| Feb 25, 2025 | Hitesh Ramani Officer | PATH UiPath, Inc. | 12,500 | $165.5K | 10b5-1 | Feb 25, 2025 | Form 4 ↗ 2 days later · 12,500 shares | Form 144 ↗ |
| Jan 3, 2025 | Ashim Gupta Officer | PATH UiPath, Inc. | 47,227 | $610.6K | 10b5-1 | Jan 3, 2025 | Form 4 ↗ 3 days later · 47,227 shares | Form 144 ↗ |
| Jan 3, 2025 | Hitesh Ramani Officer | PATH UiPath, Inc. | 25,000 | $323.3K | 10b5-1 | Jan 3, 2025 | Form 4 ↗ 3 days later · 25,000 shares | Form 144 ↗ |
| Dec 9, 2024 | Our Three Babies 2021 Trust Officer | PATH UiPath, Inc. | 55,000 | $814.5K | 10b5-1 | Dec 9, 2024 | Form 4 ↗ 2 days later · 55,000 shares | Form 144 ↗ |
| Oct 3, 2024 | Hitesh Ramani Officer | PATH UiPath, Inc. | 25,000 | $308.3K | 10b5-1 | Oct 3, 2024 | Form 4 ↗ 4 days later · 25,000 shares | Form 144 ↗ |
| Oct 3, 2024 | Ashim A Gupta Officer | PATH UiPath, Inc. | 47,227 | $582.3K | 10b5-1 | Oct 3, 2024 | Form 4 ↗ 4 days later · 47,227 shares | Form 144 ↗ |
| Sep 13, 2024 | Ashim A Gupta Officer | PATH UiPath, Inc. | 47,671 | $573.0K | 10b5-1 | Sep 13, 2024 | Form 4 ↗ 24 days later · 47,227 shares | Form 144 ↗ |
| Sep 11, 2024 | Hitesh Ramani Officer | PATH UiPath, Inc. | 25,000 | $300.8K | 10b5-1 | Sep 11, 2024 | Form 4 ↗ 26 days later · 25,000 shares | Form 144 ↗ |
| May 6, 2024 | Sireesha Edara & Sathish Iyerco-TTEE Our Three Babies 2021 Trust U/A DTD 01/29/2021 Officer | PATH UiPath, Inc. | 16,000 | $311.7K | 10b5-1 | May 6, 2024 | — | Form 144 ↗ |
| May 6, 2024 | Ashim A Gupta Officer | PATH UiPath, Inc. | 40,000 | $779.2K | 10b5-1 | May 6, 2024 | — | Form 144 ↗ |
| Apr 4, 2024 | Sireesha Edara & Sathish Iyerco-TTEE Our Three Babies 2021 Trust U/A DTD 01/29/2021 Officer | PATH UiPath, Inc. | 16,000 | $344.6K | 10b5-1 | Apr 4, 2024 | — | Form 144 ↗ |
| Apr 4, 2024 | Ashim A Gupta Officer | PATH UiPath, Inc. | 40,000 | $861.6K | 10b5-1 | Apr 4, 2024 | — | Form 144 ↗ |
| Mar 15, 2024 | Sireesha Edara & Sathish Iyerco-TTEE Our Three Babies 2021 Trust U/A DTD 01/29/2021 Officer | PATH UiPath, Inc. | 16,000 | $364.0K | 10b5-1 | Mar 15, 2024 | — | Form 144 ↗ |
| Feb 5, 2024 | Sireesha Edara & Sathish Iyerco-TTEE Our Three Babies 2021 Trustu/A DTD 01/29/2021 Officer | PATH UiPath, Inc. | 16,000 | $375.0K | 10b5-1 | Feb 5, 2024 | — | Form 144 ↗ |
| Jan 8, 2024 | Rich Wong Director | PATH UiPath, Inc. | 200,000 | $4.6M | 10b5-1 | Jan 8, 2024 | — | Form 144 ↗ |
| Jan 8, 2024 | Ashim A Gupta Officer | PATH UiPath, Inc. | 70,000 | $1.6M | 10b5-1 | Jan 8, 2024 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 4:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances